Pure Global

Effect of Coenzyme Q10 on Diabetic Children - Trial NCT06361680

Access comprehensive clinical trial information for NCT06361680 through Pure Global AI's free database. This Phase 1 trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Type 1 Diabetes Mellitus. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06361680
Phase 1
Not yet recruiting
drug
Trial Details
ClinicalTrials.gov • NCT06361680
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effect of Coenzyme Q10 on Diabetic Children
Efficacy of Coenzyme Q10 Supplementation on Metabolic Control in Children With Type 1 Diabetes Mellitus: a Randomized Clinical Trial

Study Focus

Type 1 Diabetes Mellitus

Coenzyme Q10 Cap/Tab as natural factors capsules or kirkman tablets

Interventional

drug

Sponsor & Location

Assiut University

Timeline & Enrollment

Phase 1

Oct 30, 2024

Nov 30, 2025

100 participants

Primary Outcome

Assess the effect of Coenzyme Q10 on glycated haemoglobin in type 1 diabetes mellitus

Summary

Determine the effect of Coenzyme Q10 on random blood sugar and glycosylated haemoglobin

ICD-10 Classifications

Type 1 diabetes mellitus
Type 1 diabetes mellitus with unspecified complications
Type 1 diabetes mellitus with other specified complications
Type 1 diabetes mellitus without complications
Type 1 diabetes mellitus with multiple complications

Data Source

ClinicalTrials.gov

NCT06361680

Non-Device Trial